# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-014310
Filing Date
2025-02-14
Accepted
2025-02-14 17:13:51
Documents
18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | tm2430195-17_424b3.htm | 424B3 | 10807822
2 | GRAPHIC | lg_caratmtherap-4c.jpg | GRAPHIC | 20477
3 | GRAPHIC | fc_pipeline-4clr.jpg | GRAPHIC | 43142
4 | GRAPHIC | fc_canonical-4clr.jpg | GRAPHIC | 70761
5 | GRAPHIC | fc_dualmechanism-4clr.jpg | GRAPHIC | 99307
6 | GRAPHIC | fc_centralcatalyst-4clr.jpg | GRAPHIC | 82589
7 | GRAPHIC | fc_currentpipeline-4clr.jpg | GRAPHIC | 42898
8 | GRAPHIC | fc_ipfaffected-4clr.jpg | GRAPHIC | 73450
9 | GRAPHIC | fc_lungfibrosis-4clr.jpg | GRAPHIC | 84531
10 | GRAPHIC | bc_bothextrinsic-4clr.jpg | GRAPHIC | 101044
11 | GRAPHIC | bc_dosedepen-4clr.jpg | GRAPHIC | 84572
12 | GRAPHIC | fc_evaluating-4clr.jpg | GRAPHIC | 50945
13 | GRAPHIC | fc_mousemodel-4clr.jpg | GRAPHIC | 78860
14 | GRAPHIC | fc_engrafted-4clr.jpg | GRAPHIC | 53142
15 | GRAPHIC | lc_treatment-4clr.jpg | GRAPHIC | 63705
16 | GRAPHIC | fc_clinicaltrial-4clr.jpg | GRAPHIC | 90780
17 | GRAPHIC | px_25caraproxy1pg01-bw.jpg | GRAPHIC | 305866
18 | GRAPHIC | px_25caraproxy1pg02-bw.jpg | GRAPHIC | 231322
| Complete submission text file | 0001104659-25-014310.txt |  | 12942941

Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283900 | Film No.: 25630863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)